The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Human Atherosclerotic Plaque Alternative Macrophages Display Low Cholesterol Handling but High Phagocytosis Because of Distinct Activities of the PPARγ and LXRα Pathways
Open accessAbstract
Rationale: A crucial step in atherogenesis is the infiltration of the subendothelial space of large arteries by monocytes where they differentiate into macrophages and transform into lipid-loaded foam cells. Macrophages are heterogeneous cells that adapt their response to environmental cytokines. Th1 cytokines promote monocyte differentiation into M1 macrophages, whereas Th2 cytokines trigger an “alternative” M2 phenotype. Objective: We previously reported the presence of CD68 + mannose receptor (MR) + M2 macrophages in human atherosclerotic plaques. However, the function of these plaque CD68 + MR + macrophages is still unknown. Methods and Results: Histological analysis revealed that CD68 + MR + macrophages locate far from the lipid core of the plaque and contain smaller lipid droplets compared to CD68 + MR − macrophages. Interleukin (IL)-4–polarized CD68 + MR + macrophages display a reduced capacity to handle and efflux cellular cholesterol because of low expression levels of the nuclear receptor liver x receptor (LXR)α and its target genes, ABCA1 and apolipoprotein E, attributable to the high 15-lipoxygenase activity in CD68 + MR + macrophages. By contrast, CD68 + MR + macrophages highly express opsonins and receptors involved in phagocytosis, resulting in high phagocytic activity. In M2 macrophages, peroxisome proliferator-activated receptor (PPAR)γ activation enhances the phagocytic but not the cholesterol trafficking pathways. Conclusions: These data identify a distinct macrophage subpopulation with a low susceptibility to become foam cells but high phagocytic activity resulting from different regulatory activities of the PPARγ-LXRα pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this context, a study in macrophages has shown that engulfment of cellular debris relies on the availability of free fatty acids, which are released upon degradation of lipid droplets, thus linking effective lysis of lipid droplets with successful phagocytosis47.”
From Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain (2020) · cites this paper as [47]
In the citing paper
“It has recently been appreciated that PPARs act as master regulators governing the polarization of macrophages and microglia into “M2” or “alternative” activation states associated with the suppression of inflammation and promotion of phagocytosis and tissue repair (Chawla, 2010; Chinetti-Gbaguidi et al., 2011).”
From Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease (2012) · cites this paper as Chinetti-Gbaguidi et al., 2011
In the citing paper
“PPARγ activation has been shown to enhance the phagocytic capabilities of peripheral M2 polarized macrophages (Chinetti-Gbaguidi et al., 2011).”
From Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease (2012) · cites this paper as Chinetti-Gbaguidi et al., 2011
In the citing paper
“Thus, modulating microglial activation status by targeting nuclear receptors appears to restore the competence of these cells to phagocytose and clear amyloid in the AD brain (Mukundan et al., 2009; Chinetti-Gbaguidi et al., 2011).”
From Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease (2012) · cites this paper as Chinetti-Gbaguidi et al., 2011
Citations
Cites
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Warlow, C. P. (1991) · The Lancet · doi:10.1016/0140-6736(91)92916-p · Cited by 3,332
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960
Role of LXRs in control of lipogenesis
Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000) · Genes & Development · doi:10.1101/gad.850400 · Cited by 1,499
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Greaves, D. R., Murray, P. J., & Chawla, A. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.011 · Cited by 1,369
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
Self-citationNiemann-Pick C1 Disease Gene: Homology to Mediators of Cholesterol Homeostasis
Carstea, E. D., Morris, J. A., Coleman, K. G., Loftus, S. K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M. A., Pavan, W. J., Krizman, D. B., et al. (1997) · Science · doi:10.1126/science.277.5323.228 · Cited by 1,293
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Self-citation
Cited by
Sorted by citations
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Modulation of macrophage phenotype by cell shape
McWhorter, F. Y., Wang, T., Nguyen, P., Chung, T., & Liu, W. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308887110 · Cited by 1,482
Marschallinger, J., Iram, T., Zardeneta, M., Lee, S. E., Lehallier, B., Haney, M. S., Pluvinage, J. V., Mathur, V., Hahn, O., Morgens, D. W., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0566-1 · Cited by 1,384
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
Pathophysiology of Atherosclerosis
Jebari‐Benslaiman, S., Galicia-García, U., Larrea, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito‐Vicente, A., & Martı́n, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,166
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Macrophage phenotypes in atherosclerosis
Colin, S., Chinetti‐Gbaguidi, G., & Staels, B. (2014) · Immunological Reviews · doi:10.1111/imr.12218 · Cited by 657
Self-citationMacrophage subsets in atherosclerosis
Chinetti, G., Colin, S., & Staels, B. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.173 · Cited by 669
Self-citationMacrophages in Atherosclerosis Regression
Barrett, T. J. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312802 · Cited by 656
Distribution of macrophage polarization markers in human atherosclerosis
Stöger, J. L., Gijbels, M. J., van der Velden, S., Manca, M., van der Loos, C. M., Biessen, E. A. L., Daemen, M. J. A. P., Lutgens, E., & de Winther, M. P. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.013 · Cited by 646
Regulation of macrophage immunometabolism in atherosclerosis
Koelwyn, G. J., Corr, E. M., Erbay, E., & Moore, K. J. (2018) · Nature Immunology · doi:10.1038/s41590-018-0113-3 · Cited by 569
Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
Libby, P., Tabas, I. A., Fredman, G., & Fisher, E. A. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302699 · Cited by 531
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
Chen, W., Schilperoort, M., Cao, Y., Shi, J., Tabas, I. A., & Tao, W. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00629-x · Cited by 544
Inflammation in atherosclerosis: pathophysiology and mechanisms
Ajoolabady, A., Praticò, D., Lin, L., Mantzoros, C. S., Bahijri, S., Tuomilehto, J. O., & Ren, J. T. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07166-8 · Cited by 532
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Fisher, E. A. A., Feig, J. E., Hewing, B., Hazen, S. L., & Smith, J. D. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300133 · Cited by 404
Ouimet, M., Ediriweera, H. N., Gundra, U. M., Sheedy, F. J., Ramkhelawon, B., Hutchison, S. B., Rinehold, K., van Solingen, C., Fullerton, M. D., Cecchini, K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81676 · Cited by 394
Macrophage polarization and meta-inflammation
Li, C., Xu, M. M., Wang, K., Adler, A. J., Vella, A. T., & Zhou, B. (2017) · Translational research · doi:10.1016/j.trsl.2017.10.004 · Cited by 376
Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease
Maguire, E. M., Pearce, S. W. A., & Xiao, Q. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.08.002 · Cited by 380
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 418
Mandrekar-Colucci, S., Karlo, J. C., & Landreth, G. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5268-11.2012 · Cited by 355
“Thus, modulating microglial activation status by targeting nuclear receptors appears to restore the competence of these cells to phagocytose and clear amyloid in the AD brain (Mukundan et al., 2009; Chinetti-Gbaguidi et al., 2011).”
BackgroundMacrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis
Bobryshev, Y. V., Ivanova, E. A., Chistiakov, D. A., Nikiforov, N. G., & Orekhov, A. N. (2016) · BioMed Research International · doi:10.1155/2016/9582430 · Cited by 369
Micro- and Nanopatterned Topographical Cues for Regulating Macrophage Cell Shape and Phenotype
Luu, T. U., Gott, S. C., Woo, B. W. K., Rao, M. P., & Liu, W. F. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b10589 · Cited by 344
Finn, A. V., Nakano, M., Polavarapu, R., Karmali, V., Saeed, O., Zhao, X., Yazdani, S. K., Otsuka, F., Davis, T., Habib, A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.852 · Cited by 330
Endoplasmic Reticulum Stress Controls M2 Macrophage Differentiation and Foam Cell Formation
Oh, J., Riek, A. E., Weng, S., Petty, M., Kim, D., Colonna, M., Cella, M., & Bernal‐Mizrachi, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338673 · Cited by 313
Cervantes-Gracia, K., Llanas-Cornejo, D., & Husi, H. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6020022 · Cited by 320
Cardilo‐Reis, L., Gruber, S., Schreier, S. M., Drechsler, M., Papac‐Milicevic, N., Weber, C., Wagner, O., Stangl, H., Soehnlein, O., & Binder, C. J. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201374 · Cited by 292
Inflammation and immune system interactions in atherosclerosis
Legein, B., Temmerman, L., Biessen, E. A. L., & Lutgens, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1289-1 · Cited by 300
Spatial confinement downsizes the inflammatory response of macrophages
Jain, N., & Vogel, V. (2018) · Nature Materials · doi:10.1038/s41563-018-0190-6 · Cited by 271
Plaque Calcification During Atherosclerosis Progression and Regression
Shioi, A., & Ikari, Y. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17020 · Cited by 271
Phenotypic Polarization of Macrophages in Atherosclerosis
Leitinger, N., & Schulman, I. G. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300173 · Cited by 259
Jain, N., Moeller, J., & Vogel, V. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121224 · Cited by 237
Mohammadi, A., Blesso, C. N., Barreto, G. E., Banach, M., Majeed, M. A., & Sahebkar, A. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.12.005 · Cited by 229
Atherosclerosis – A matter of unresolved inflammation
Viola, J. R., & Soehnlein, O. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.013 · Cited by 229
The “Sweet” Side of the Protein Corona: Effects of Glycosylation on Nanoparticle–Cell Interactions
Wan, S., Kelly, P. M., Mahon, E., Stöckmann, H., Rudd, P. M., Caruso, F., Dawson, K. A., Yan, Y., & Monopoli, M. P. (2015) · ACS Nano · doi:10.1021/nn506060q · Cited by 223
Boyle, J. J., Johns, M. S., Kämpfer, T., Nguyen, A. T., Gamé, L., Schaer, D. J., Mason, J. C., & Haskard, D. O. (2011) · Circulation Research · doi:10.1161/circresaha.111.247577 · Cited by 230
Macrophage polarization in atherosclerosis
Yang, S., Yuan, H., Hao, Y., Ren, Z., Qu, S.-L., Liu, L., Wei, D., Tang, Z., Zhang, J., & Jiang, Z. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.10.034 · Cited by 219
Diversity of macrophage phenotypes and responses in atherosclerosis
Jinnouchi, H., Guo, L., Sakamoto, A., Torii, S., Sato, Y., Cornelissen, A., Kuntz, S. H., Paek, K. H., Fernandez, R., Fuller, D. T., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03371-3 · Cited by 226
Macrophage Phenotypes and Their Modulation in Atherosclerosis
Paoli, F. D., Staels, B., & Chinetti, G. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0621 · Cited by 214
Self-citationDynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression
Peled, M., & Fisher, E. A. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00579 · Cited by 212
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background
Jones, S. W., Roberts, R. A., Robbins, G. R., Perry, J. L., Kai, M. P., Chen, K., Bo, T., Napier, M. E., Ting, J. P. ‐., DeSimone, J. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66895 · Cited by 202
Image based Machine Learning for identification of macrophage subsets
Rostam, H. M., Reynolds, P. M., Alexander, M. R., Gadegaard, N., & Ghaemmaghami, A. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-03780-z · Cited by 196
Macrophage polarization in metabolic disorders
Chinetti, G., & Staels, B. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834a77b4 · Cited by 193
Self-citationWolfs, I., Donners, M., & de Winther, M. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0320 · Cited by 157
Chistiakov, D. A., Bobryshev, Y. V., Nikiforov, N. G., Elizova, N. V., Sobenin, I. A., & Orekhov, A. N. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.055 · Cited by 184
RetractedAtherogenesis and iron: from epidemiology to cellular level
Vinchi, F., Muckenthaler, M. U., da Silva, M. C., Balla, G. J., Balla, J., & Jeney, V. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00094 · Cited by 176
Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
Squadrito, M. L., & Palma, M. D. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.005 · Cited by 174
Nuclear Receptors License Phagocytosis by Trem2+Myeloid Cells in Mouse Models of Alzheimer's Disease
Savage, J. C., Jay, T., Goduni, E., Quigley, C., Mariani, M. M., Malm, T., Ransohoff, R. M., Lamb, B. T., & Landreth, G. E. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4586-14.2015 · Cited by 154
“Nuclear receptor actions in tissue macrophages have been observed on a cohort of genes that are specifically associated with “alternative activation” and phagocytosis (Odegaard et al., 2007; A-Gonzalez et al., 2009; Chinetti-Gbaguidi et al., 2011; Röszer et al., 2013).”
BackgroundM1- and M2-Type Macrophage Responses Are Predictive of Adverse Outcomes in Human Atherosclerosis
de Gaetano, M., Crean, D., Barry, M. C., & Belton, O. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00275 · Cited by 164
Macrophage Plasticity and Atherosclerosis Therapy
Lin, P. C., Ji, H., Li, Y., & Guo, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.679797 · Cited by 171
Oh, J., Riek, A. E., Darwech, I., Funai, K., Shao, J.-S., Chin, K., Sierra, O. L., Carmeliet, G., Ostlund, R. E., & Bernal‐Mizrachi, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.043 · Cited by 157
Innate immunity and monocyte-macrophage activation in atherosclerosis
Shalhoub, J., Falck-Hansen, M., Davies, A. H., & Monaco, C. G. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-9 · Cited by 160
M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment
Bi, Y., Chen, J., Hu, F., Liu, J., Li, M., & Zhao, L. (2019) · Neural Plasticity · doi:10.1155/2019/6724903 · Cited by 158
Immunobiology of Atherosclerosis: A Complex Net of Interactions
Herrero‐Fernández, B., Gómez-Bris, R., Somovilla-Crespo, B., & González, J. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215293 · Cited by 158
Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
MacKinnon, A. C., Liu, X., Hadoke, P. W. F., Miller, M. R., Newby, D. E., & Sethi, T. (2013) · Glycobiology · doi:10.1093/glycob/cwt006 · Cited by 147
The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis
Fenyo, I. M., & Gafencu, A. V. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.005 · Cited by 148
Macrophage metabolism in atherosclerosis
Bories, G. F. P., & Leitinger, N. (2017) · FEBS Letters · doi:10.1002/1873-3468.12786 · Cited by 145
Self-citationFadini, G. P., de Kreutzenberg, S. V., Boscaro, E., Albiero, M., Cappellari, R., Kränkel, N., Landmesser, U., Toniolo, A., Bolego, C., Cignarella, A., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2918-9 · Cited by 141
Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1α-ADAM17 pathway✰
Lian, G., Li, X., Zhang, L., Zhang, Y., Sun, L., Zhang, X., Liu, H., Pang, Y., Kong, W., Zhang, T., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.041 · Cited by 139
Challenges and advances in the management of inflammation in atherosclerosis
Xing, Y., & Lin, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.016 · Cited by 147
Atherosclerosis and immunity: A perspective
Abdolmaleki, F., Hayat, S. M. G., Bianconi, V., Johnston, T. P., & Sahebkar, A. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.09.017 · Cited by 138
Vitamin D Deficiency Induces High Blood Pressure and Accelerates Atherosclerosis in Mice
Weng, S., Sprague, J., Oh, J., Riek, A. E., Chin, K., Garcia, M., & Bernal‐Mizrachi, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054625 · Cited by 131
Suzuki, H., Kayama, Y., Sakamoto, M., Iuchi, H., Shimizu, I., Yoshino, T., Katoh, D., Nagoshi, T., Tojo, K., Minamino, T., et al. (2014) · Diabetes · doi:10.2337/db13-1896 · Cited by 131
Kurapati, K. R. V., Atluri, V. S. R., Samikkannu, T., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077624 · Cited by 130
Attributes of alternatively activated (M2) macrophages
Shrivastava, R., & Shukla, N. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.062 · Cited by 132
McClean, C. M., & Tobin, D. M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw068 · Cited by 135
Stroke induces disease-specific myeloid cells in the brain parenchyma and pia
Beuker, C., Schafflick, D., Strecker, J., Heming, M., Li, X., Wolbert, J., Schmidt‐Pogoda, A., Thomas, C., Kuhlmann, T., Aranda-Pardos, I., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28593-1 · Cited by 126
Riek, A. E., Oh, J., Sprague, J., Timpson, A., Fuentes, L. D. L., Bernal‐Mizrachi, L., Schechtman, K. B., & Bernal‐Mizrachi, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386912 · Cited by 120
Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy
Momtazi‐Borojeni, A. A., Abdollahi, E., Nikfar, B., Chaichian, S., & Ekhlasi‐Hundrieser, M. (2019) · Heart Failure Reviews · doi:10.1007/s10741-018-09764-z · Cited by 123
Extracellular MicroRNA-92a Mediates Endothelial Cell–Macrophage Communication
Chang, Y., Li, Y.-S. J., Wu, C., Wang, K.-C., Huang, T.-C., Chen, Z., & Chien, S. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312707 · Cited by 116
Paraoxonase 1 (PON1) reduces macrophage inflammatory responses
Aharoni, S., Aviram, M., & Fuhrman, B. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.005 · Cited by 117
Hadri, K. E., Mahmood, D. F. D., Couchie, D., Jguirim-Souissi, I., Genze, F., Diderot, V., Syrovets, T., Lunov, O., Simmet, T., & Rouis, M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.249334 · Cited by 118
Zizzo, G., & Cohen, P. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0081-4 · Cited by 94
Innate Immune System Cells in Atherosclerosis
Chávez-Sanchéz, L., Espinosa-Luna, J. E., Chávez-Rueda, A. K., Legorreta-Haquet, M. V., Montoya-Díaz, E., & Blanco-Favela, F. A. (2013) · Archives of Medical Research · doi:10.1016/j.arcmed.2013.11.007 · Cited by 109
Okamoto, T., Takagi, Y., Kawamoto, E., Park, E. J., Usuda, H., Wada, K., & Shimaoka, M. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.04.005 · Cited by 106
Binnemars‐Postma, K., ten Hoopen, H., Storm, G., & Prakash, J. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0233 · Cited by 103
Ding, Y., Qian, L.-Y., Pang, J., Lin, J., Xu, Q., Wang, L., Huang, D., & Zou, H. (2017) · Oncotarget · doi:10.18632/oncotarget.18346 · Cited by 103
The CD44-HA axis and inflammation in atherosclerosis: A temporal perspective
Krolikoski, M., Monslow, J., & Puré, E. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.007 · Cited by 105
Pathophysiological relevance of macrophage subsets in atherogenesis
Liberale, L., Dallegri, F., Carbone, F., & Montecucco, F. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-08-0593 · Cited by 103
Changes in transcriptome of macrophages in atherosclerosis
Chistiakov, D. A., Bobryshev, Y. V., & Orekhov, A. N. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12591 · Cited by 103
Chinetti, G., Daoudi, M., Rosa, M., Vinod, M., Louvet, L., Copin, C., Fanchon, M., Vanhoutte, J., Derudas, B., Belloy, L., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.310262 · Cited by 99
Self-citationThe Role of Bone Morphogenetic Protein 7 (BMP-7) in Inflammation in Heart Diseases
Narasimhulu, C. A., & Singla, D. K. (2020) · Cells · doi:10.3390/cells9020280 · Cited by 102
Chen, W., Li, X., Guo, S., Song, N., Wang, J., Jia, L., & Zhu, A. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.054 · Cited by 94
Liver X Receptor Activation Stimulates Iron Export in Human Alternative Macrophages
Bories, G. F. P., Colin, S., Vanhoutte, J., Derudas, B., Copin, C., Fanchon, M., Daoudi, M., Belloy, L., Haulon, S., Zawadzki, C., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301656 · Cited by 101
Self-citationZarić, B. L., Radovanović, J., Gluvic, Z. M., Stewart, A. J., Essack, M., Motwalli, O., Gojobori, T., & Isenović, E. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.551758 · Cited by 94
KONES, R. J. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s37119 · Cited by 91
Xu, H., She, P., Ma, B., Zhao, Z., Li, G., & Wang, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121734 · Cited by 88
Plaque neovascularization: defense mechanisms, betrayal, or a war in progress
Moreno, P., Purushothaman, M., & Purushothaman, K. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06497.x · Cited by 95
Thulin, P., Wei, T., Werngren, O., Cheung, L. K., Fisher, R. M., Grandér, D., Corcoran, M., & Ehrenborg, E. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1311 · Cited by 88
Macrophage Function and Polarization in Cardiovascular Disease
Bolego, C., Cignarella, A., Staels, B., & Chinetti, G. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301328 · Cited by 85
Self-citationTranscriptional regulation of macrophage arginase 1 expression and its role in atherosclerosis
Pourcet, B., & Pineda‐Torra, I. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.10.003 · Cited by 82
Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis
Bruen, R., Curley, S., Kajani, S., Crean, D., O'Reilly, M. E., Lucitt, M. B., Godson, C., McGillicuddy, F. C., & Belton, O. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0626-3 · Cited by 85
Song, L., Zhang, J., Ma, D., Fan, Y., Lai, R., Tian, W., Zhang, Z., Ju, J., & Xu, H. Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.910444 · Cited by 79
Park, S.-J., Lee, K., Kang, S., Lee, J., Sato, K., Chung, H. Y., Okajima, F., & Im, D. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.009 · Cited by 79
Metabolism Plays a Key Role during Macrophage Activation
Stunault, M. I., Bories, G. F. P., Guinamard, R., & Ivanov, S. (2018) · Mediators of Inflammation · doi:10.1155/2018/2426138 · Cited by 86
Self-citationLee, M. K. S., Moore, X., Fu, Y., Al‐Sharea, A., Dragoljevic, D., Fernandez-Rojo, M. A., Parton, R. G., Sviridov, D., Murphy, A. J., & Chin-Dusting, J. P. F. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13319 · Cited by 80
Boyle, J. J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328356b145 · Cited by 84
Boytard, L., Spear, R., Chinetti, G., Acosta‐Martin, A. E., Vanhoutte, J., Lamblin, N., Staels, B., Amouyel, P., Haulon, S., & Pinet, F. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300663 · Cited by 78
Self-citationSchaper, F., de Leeuw, K., Horst, G., Bootsma, H., Limburg, P. C., Heeringa, P., Bijl, M., & Westra, J. (2016) · Lara D. Veeken · doi:10.1093/rheumatology/kew324 · Cited by 78
Malm, T., Mariani, M., Donovan, L. J., Neilson, L., & Landreth, G. E. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0229-9 · Cited by 77
Johnson, J. L., Jenkins, N. P., Huang, W., Gregoli, K. D., Sala‐Newby, G. B., Scholtes, V. P. W., Moll, F. L., Pasterkamp, G., & Newby, A. C. (2014) · Mediators of Inflammation · doi:10.1155/2014/276457 · Cited by 77
Metadata
- Authors
- Chinetti-Gbaguidi, G., Baron, M., Bouhlel, M. A., Vanhoutte, J., Copin, C., Sebti, Y., Derudas, B., Mayi, T., Bories, G., Tailleux, A., Haulon, S., Zawadzki, C., Jude, B., & Staels, B.
- Affiliations
- From Univ Lille Nord de France (G.C.-G., M.B., M.A.B., J.V., C.C., Y.S., B.D., T.M., G.B., A.T., C.Z., B.J., B.S.), F-59000, Lille; Inserm (G.C.-G., M.B., M.A.B., J.V., C.C., Y.S., B.D., T.M., G.B., A.T., B.S.), U1011, F-59000, Lille; UDSL (G.C.-G., M.B., M.A.B., J.V., C.C., Y.S., B.D., T.M., G.B., A.T., C.Z., B.J., B.S.), F-59000, Lille, France; Institut Pasteur de Lille (G.C.-G., M.B., M.A.B., J.V., C.C., Y.S., B.D., T.M., G.B., A.T., B.S.), F-59019, Lille; and EA2693 and Centre Hospitalier...
- Inserm (FR)
- ORCID
- Venue
- Circulation Research
- Published
- 2011-04-15
- Volume
- 108
- Issue
- 8
- Pages
- 985-995
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC3319502
- OpenAlex
- W2129909114
- Cited by
- 387
- References
- 43
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 25 · 2023: 22 · 2022: 34 · 2021: 17 · 2020: 21 · 2019: 30 · 2018: 26 · 2017: 30 · 2016: 21 · 2015: 28 · 2014: 25 · 2013: 29 · 2012: 31
- FWCI
- 14.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- M2 macrophages, CD206, CD68, phagocytosis, cholesterol efflux, ABCA1, apolipoprotein E, liver X receptor alpha, PPARγ, 15-lipoxygenase, foam cells, macrophage heterogeneity, opsonins
- MeSH terms
- Liver X Receptors, Cell Differentiation, Cells, Cultured, Cholesterol, Humans, Leukocytes, Mononuclear, Macrophages, Phagocytosis, Genetic Predisposition to Disease, PPAR gamma, Orphan Nuclear Receptors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
